(Q40714674)

English

The novel catecholaminergic and serotoninergic activity enhancer R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane up-regulates neurotrophic factor synthesis in mouse astrocytes

scientific article published on August 2002

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

23 September 2017

The novel catecholaminergic and serotoninergic activity enhancer R-(-)-1-(benzofuran-2-yl)-2-propylaminopentane up-regulates neurotrophic factor synthesis in mouse astrocytes (English)

1 reference

Europe PubMed Central

23 September 2017

1 reference

based on heuristic

inferred from title

author name string

Kiyoe Ohta

1

1 reference

Europe PubMed Central

23 September 2017

Mitsuhiro Ohta

2

1 reference

Europe PubMed Central

23 September 2017

Ikuko Mizuta

3

1 reference

Europe PubMed Central

23 September 2017

Aya Fujinami

4

1 reference

Europe PubMed Central

23 September 2017

Seiichiro Shimazu

5

1 reference

Europe PubMed Central

23 September 2017

Noriyuki Sato

6

1 reference

Europe PubMed Central

23 September 2017

Fumio Yoneda

7

1 reference

Europe PubMed Central

23 September 2017

Kyozo Hayashi

8

1 reference

Europe PubMed Central

23 September 2017

Sadako Kuno

9

1 reference

Europe PubMed Central

23 September 2017

language of work or name

0 references

publication date

1 August 2002

1 reference

Europe PubMed Central

23 September 2017

Neuroscience Letters

1 reference

Europe PubMed Central

23 September 2017

328

1 reference

Europe PubMed Central

23 September 2017

3

1 reference

Europe PubMed Central

23 September 2017

205-208

1 reference

Europe PubMed Central

23 September 2017

The transforming growth factor-betas: structure, signaling, and roles in nervous system development and functions

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential effects of GDNF and BDNF on cultured ventral mesencephalic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

(-)1-(Benzofuran-2-yl)-2-propylaminopentane shows survival effect on cortical neurons under serum-free condition through sigma receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

BDNF is a neurotrophic factor for dopaminergic neurons of the substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Enhanced catecholaminergic and serotoninergic activity in rat brain from weaning to sexual maturity: rationale for prophylactic (-)deprenyl (selegiline) medication.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

(-)1-(Benzofuran-2-yl)-2-propylaminopentane, [(-)BPAP], a selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Neurotrophic factors: from molecule to man.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

GDNF and NT-4 protect midbrain dopaminergic neurons from toxic damage by iron and nitric oxide.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Selegiline and desmethylselegiline stimulate NGF, BDNF, and GDNF synthesis in cultured mouse astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Medial nigral dopamine neurons have rich neurotrophin support in humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Apomorphine up-regulates NGF and GDNF synthesis in cultured mouse astrocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Reduced expression of brain-derived neurotrophic factor protein in Parkinson's disease substantia nigra.

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

(-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in rats due to its ability to induce dopamine release

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Brain-derived neurotrophic factor pretreatment exerts a partially protective effect against glutamate-induced neurotoxicity in cultured rat cortical neurons

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Modulation of gene expression rather than monoamine oxidase inhibition: (-)-deprenyl-related compounds in controlling neurodegeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

GDNF: a novel factor with therapeutic potential for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Structure-activity studies leading to (-)1-(benzofuran-2-yl)-2-propylaminopentane, ((-)BPAP), a highly potent, selective enhancer of the impulse propagation mediated release of catecholamines and serotonin in the brain

1 reference

https://api.crossref.org/works/10.1016%2FS0304-3940%2802%2900461-5

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0304-3940(02)00461-5

1 reference

Europe PubMed Central

23 September 2017

1 reference

Europe PubMed Central

23 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40714674&oldid=2132037250"